Title

Novel oncolytic herpes simplex virus 1 VC2 promotes long-lasting, systemic anti-melanoma tumor immune responses and increased survival in an immunocompetent B16F10-derived mouse melanoma model

Document Type

Article

Publication Date

1-1-2021

Publication Source (Journal or Book title)

Journal of Virology

This document is currently not available here.

Share

COinS